Oregon Public Employees Retirement Fund’s Charles River Laboratories CRL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.35M Buy
5,945
+300
+5% +$53.4K 0.01% 777
2026
Q1
$974K Hold
5,645
0.01% 860
2025
Q4
$1.13M Hold
5,645
0.01% 789
2025
Q3
$883K Buy
5,645
+1,361
+32% +$216K 0.01% 913
2025
Q2
$650K Sell
4,284
-100
-2% -$13.3K 0.01% 998
2025
Q1
$660K Hold
4,384
0.01% 993
2024
Q4
$809K Sell
4,384
-40
-0.9% -$7.71K 0.01% 904
2024
Q3
$871K Hold
4,424
0.02% 874
2024
Q2
$914K Buy
4,424
+45
+1% +$10.2K 0.02% 803
2024
Q1
$1.19M Buy
4,379
+403
+10% +$96.2K 0.02% 731
2023
Q4
$940K Sell
3,976
-15
-0.4% -$2.95K 0.02% 917
2023
Q3
$782K Sell
3,991
-37
-0.9% -$7.6K 0.01% 1083
2023
Q2
$847K Buy
4,028
+100
+3% +$19.9K 0.01% 1085
2023
Q1
$793K Buy
3,928
+28
+0.7% +$6.35K 0.01% 1101
2022
Q4
$850K Hold
3,900
0.01% 1055
2022
Q3
$768K Sell
3,900
-76
-2% -$16.4K 0.01% 1061
2022
Q2
$851K Sell
3,976
-8,214
-67% -$2.01M 0.01% 895
2022
Q1
$3.46M Buy
12,190
+66
+0.5% +$20.4K 0.04% 476
2021
Q4
$4.57M Sell
12,124
-1,050
-8% -$408K 0.05% 324
2021
Q3
$5.44M Buy
13,174
+700
+6% +$291K 0.06% 282
2021
Q2
$4.61M Sell
12,474
-4,061
-25% -$1.36M 0.05% 321
2021
Q1
$4.79M Buy
16,535
+60
+0.4% +$16.7K 0.06% 297
2020
Q4
$4.12M Sell
16,475
-337
-2% -$80.3K 0.05% 306
2020
Q3
$3.81M Sell
16,812
-1,612
-9% -$335K 0.06% 294
2020
Q2
$3.21M Buy
18,424
+100
+0.5% +$16K 0.05% 334
2020
Q1
$2.31M Sell
18,324
-135
-0.7% -$20.2K 0.04% 392
2019
Q4
$2.82M Sell
18,459
-1,629
-8% -$226K 0.04% 435
2019
Q3
$2.66M Buy
20,088
+615
+3% +$82.5K 0.04% 507
2019
Q2
$2.76M Buy
19,473
+276
+1% +$37.4K 0.04% 478
2019
Q1
$2.79M Hold
19,197
0.04% 438
2018
Q4
$2.17M Buy
19,197
+304
+2% +$38.1K 0.03% 505
2018
Q3
$2.54M Buy
18,893
+484
+3% +$59.7K 0.04% 515
2018
Q2
$2.07M Buy
18,409
+536
+3% +$57.9K 0.03% 608
2018
Q1
$1.91M Buy
17,873
+118
+0.7% +$12.7K 0.03% 627
2017
Q4
$1.94M Buy
17,755
+193
+1% +$21K 0.03% 616
2017
Q3
$1.9M Buy
17,562
+363
+2% +$37.3K 0.03% 609
2017
Q2
$1.74M Buy
17,199
+753
+5% +$69.3K 0.03% 641
2017
Q1
$1.48M Buy
16,446
+200
+1% +$17K 0.03% 583
2016
Q4
$1.24M Hold
16,246
0.03% 643
2016
Q3
$1.35M Buy
16,246
+475
+3% +$39.8K 0.03% 580
2016
Q2
$1.3M Buy
15,771
+379
+2% +$31.2K 0.03% 639
2016
Q1
$1.17M Buy
15,392
+604
+4% +$44.7K 0.03% 657
2015
Q4
$1.19M Hold
14,788
0.03% 641
2015
Q3
$939K Buy
14,788
+100
+0.7% +$7.18K 0.02% 722
2015
Q2
$1.03M Buy
14,688
+200
+1% +$14.8K 0.02% 729
2015
Q1
$1.15M Buy
14,488
+800
+6% +$59K 0.03% 688
2014
Q4
$871K Hold
13,688
0.02% 774
2014
Q3
$818K Sell
13,688
-200
-1% -$11.4K 0.02% 778
2014
Q2
$743K Buy
13,888
+200
+1% +$11K 0.02% 821
2014
Q1
$826K Sell
13,688
-100
-0.7% -$5.83K 0.02% 759
2013
Q4
$731K Buy
13,788
+3,300
+31% +$166K 0.02% 791
2013
Q3
$485K Buy
10,488
+100
+1% +$4.59K 0.02% 790
2013
Q2
$426K Buy
+10,388
New +$445K 0.02% 799

Other funds holding CRL

Oregon Public Employees Retirement Fund's CRL Position: Q2 2026 in Review

Oregon Public Employees Retirement Fund increased its Charles River Laboratories (CRL) stake by 5.3% in Q2 2026, buying an estimated $53.4K and bringing the position to 5,945 shares worth $1.35M. The position accounts for 0.01% of the portfolio, ranked #777.

Oregon Public Employees Retirement Fund first reported a position in CRL in Q2 2013 and has held it in 53 quarters since. The position peaked at $5.44M in Q3 2021. 260 funds tracked by Wall St. Rank hold CRL as of Q2 2026.

  • Oregon Public Employees Retirement Fund held 5,945 shares of Charles River Laboratories worth $1.35M as of Q2 2026.
  • Oregon Public Employees Retirement Fund bought 300 Charles River Laboratories shares in Q2 2026, an estimated $53.4K.
  • Charles River Laboratories made up 0.01% of Oregon Public Employees Retirement Fund's portfolio in Q2 2026, its #777 holding.
  • Oregon Public Employees Retirement Fund first reported a position in Charles River Laboratories in Q2 2013 and has held it in 53 quarters since.
  • Oregon Public Employees Retirement Fund's Charles River Laboratories position peaked at $5.44M in Q3 2021.
  • 260 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2026.

Based on Oregon Public Employees Retirement Fund's 13F filing for Q2 2026, filed 29 Jul 2026.